(Q85987446)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

David Booth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jacob George

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

119-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ng.2537

22 February 2020

exact match

0 references

cites work

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

1 reference

12 December 2020

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

1 reference

12 December 2020

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 December 2020

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

1 reference

12 December 2020

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

12 December 2020

Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.

1 reference

12 December 2020

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

1 reference

12 December 2020

Identifiers

DOI

10.1038/NG.2537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358218%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

0 references

1 reference